ArticleScientific reports2025
Pilot implementation result of frequency, distribution, and factors associated with unsuccessful tests and error rates at Truenat sites in Nigeria.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evaluation of the Truenat® chip-based real-time PCR platform for infectious disease diagnostics.Practical laboratory medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
Study was designed to determine frequency and distribution of unsuccessful test results and factors associated with high Error rates (ER) in Truenat sites in Nigeria. A retrospective cross-sectional study was done involving secondary data analysis of 38 Truenat facilities between January and December 2022. Socio-demographic information of key Truenat lab staff were collected. High ER was determined by proportion of health facilities with > 3% unsuccessful tests. A total of 56,799 Trueprep DNA extractions were conducted, unsuccessful tests were 1043. (ER = 1.8%). For Truenat MTB, 56,749 tests were conducted and 1350 were unsuccessful. (ER = 2.4%). High Trueprep DNA extraction test errors was recorded in 23.7% of facilities and 31.6% for Truenat MTB tests. No factor significantly influenced any of the test errors. Unsuccessful Trueprep test error codes were 1021 while unsuccessful Truelab test error codes were 1198. Highest Trueprep error recorded was cartridge error (44.1%), while highest Truelab error was internal control not amplifying in PCR (78%). Implementation of Truenat as a new tool for TB diagnosis in Nigeria is associated with low ERs. It is recommended that Truenat training curriculum in-country be updated to focus on and address the possible underlying causes of these errors as the country plans for scale up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.